| |
| | Viral Hepatitis Conference to Take Place February 27-28, 2006 in Boston, MA |
 | | BOSTON, Oct. 18 /PRNewswire/ -- Chronic hepatitis C (HCV) and B (HBV) are the most common causes of chronic viral hepatitis in the United States, posing serious risks for long-term medical complications, especially if left untreated. |
 | | By attending this industrial and networking conference you will be able to interact with many of the leading research scientists and decision-makers from the pharmaceutical/biotech industry, public health, and academic communities working in the area of viral hepatitis of North America and internationally. |
 | | Some of the topics covered include nucleoside and non-nucleoside polymerase inhibitors, protease inhibitors, other antiviral initiatives such as direct antiviral and immune approaches, HCV vaccines, etc. To request a copy of the conference agenda, please contact the conference organizer Glenn Pascual of Strategic Research Institute at gpascual@srinstitute.com or 212.967.0095, ext. |
| www.prnewswire.com /cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-18-2005/0004171604&EDATE= (555 words) |
|